A lack of concrete timetables has some concerned that the 21st Century Cures Act, now signed into law, could take years to implement
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
The latest episode of Genentech’s new show (Two Scientists Walk Into A Bar) looks at cell to cell communication, and what goes wrong when disease strikes
Latest results from the PGen Study show how customers respond to common cancer risk information from direct-to-consumer tests
New consortium set up to provide streamlined discovery and access to molecular data from patient derived xenografts
Genomics innovations, from sequencing to molecular assays, feature heavily in a roundup of top scientific innovations for 2016
GRAIL has launched its first major clinical venture to characterise the landscape of cell-free DNA in both people with cancer and without
Our roundup of all the latest opinion on the 21st Century Cures Act as it passes from a successful vote in the House to a vote in the Senate